Effects of Metformin Dose on Cancer Risk T2D

The magnitude of cancer risk reduction and prolonged cancer onset times produced by metformin in patients with type 2 diabetes depended on the dose of metformin, regardless of whether metformin was used alone or combined with other antidiabetic drugs (Pharmacotherapy)